Takeda M&A hunt, Allergan acquisition send smaller drugmakers higher
September 14, 2016 at 15:53 PM EDT
Takeda Pharmaceutical, Japan's largest drugmaker, is reportedly setting aside up to $20B as it hunts for acquisitions in the U.S.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.